ClinicalTrials.Veeva

Menu

Comparison of NIV-NAVA vs. N-CPAP After Extubation in Preterm Infants Study

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Endotracheal Extubation
Infant, Premature

Treatments

Device: N-CPAP
Device: NIV-NAVA

Study type

Interventional

Funder types

Other

Identifiers

NCT02590757
2015-1917

Details and patient eligibility

About

This study is a randomized controlled study to compare if a a non-invasive neurally adjusted ventilatory assist (NIV-NAVA) is better than nasal continuous positive airway pressure (N-CPAP) after extubation in infants' < 30 weeks of gestation.

Enrollment

78 patients

Sex

All

Ages

2 days to 6 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • postconceptional age less than 30+0 weeks
  • infants who fulfill the the criteria for extubation for 6 hours extubation criteria: Ventilator rate ≤ 25 breaths/min, Peak inspiratory pressure (PIP) ≤ 16cmH2O, Fractional inspired oxygen (FiO2) ≤ 0.3

Exclusion criteria

  • conditions which will decrease life expectancy
  • major anomalies which will decrease life expectancy
  • any anomalous conditions which involve upper and lower airway
  • neuromuscular disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

78 participants in 2 patient groups

NIV-NAVA
Active Comparator group
Description:
Noninvasive ventilation in this group is practiced with NIV-NAVA
Treatment:
Device: NIV-NAVA
N-CPAP
Active Comparator group
Description:
Patients in this group will receive nasal continuous positive airway pressure as routinely in neonatal intensive care unit.
Treatment:
Device: N-CPAP

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems